Dexcel Pharma Technologies Ltd.

Insider Reports History

Entity
Company
Location
1 Dexcel Street, Or Akiva, Israel
Signature
/s/ Dexcel Pharma Technologies Ltd. by Dan Oren, Executive Chairman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dexcel Pharma Technologies Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Roivant Sciences Ltd. 10%+ Owner Common Shares 103M $1.06B $10.35 Nov 10, 2022 Direct
Protalix BioTherapeutics, Inc. 10%+ Owner Common Stock 3.64M $5.13M $1.41 Jun 3, 2021 Direct

Insider Reports Filed by Dexcel Pharma Technologies Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ROIV Roivant Sciences Ltd. Nov 10, 2022 1 $20M 4 Nov 14, 2022 10%+ Owner
ROIV Roivant Sciences Ltd. Apr 22, 2022 2 $155K 4 Apr 26, 2022 10%+ Owner
ROIV Roivant Sciences Ltd. Oct 1, 2021 0 $0 3 Oct 1, 2021 10%+ Owner
PLX Protalix BioTherapeutics, Inc. Jun 2, 2021 2 -$2.09M 4 Jun 3, 2021 10%+ Owner